Hepatitis C

Work in progress for improving hepatitis treatment services in New Zealand.

Hepatitis C is a viral infection affecting over 50,000 New Zealanders, although it is estimated only half are currently diagnosed. Untreated, 20–25% will develop cirrhosis, and without successful treatment, 5–10% of those with cirrhosis will progress to life-threatening liver cancer or liver failure every year.

People at risk include those who have:

  • ever injected drugs
  • ever received a tattoo or body piercing using unsterile equipment
  • had a blood transfusion before 1992
  • ever lived or received medical treatment in a high risk country
  • ever been in prison
  • been born to a mother living with hepatitis C.

There have been major advances in the treatment of hepatitis C through new PHARMAC funded treatments. DHB regions have also revised the delivery of hepatitis C services by integrating service delivery across primary and secondary care. More information about both of these developments is outlined in the following pages.

In this section

Back to top